APA

Li S. R., Yang Q., Koller E., Kurtaran A., Bischof C., Leimer M., Rauscha F., Pidlich J. & Virgolini I. (19971120). Modified LDL decreases the binding of prostaglandin E2, I2, and E1 onto monocytes in patients with peripheral vascular disease. : Arteriosclerosis, thrombosis, and vascular biology.

Chicago

Li S R, Yang Q, Koller E, Kurtaran A, Bischof C, Leimer M, Rauscha F, Pidlich J and Virgolini I. 19971120. Modified LDL decreases the binding of prostaglandin E2, I2, and E1 onto monocytes in patients with peripheral vascular disease. : Arteriosclerosis, thrombosis, and vascular biology.

Harvard

Li S. R., Yang Q., Koller E., Kurtaran A., Bischof C., Leimer M., Rauscha F., Pidlich J. and Virgolini I. (19971120). Modified LDL decreases the binding of prostaglandin E2, I2, and E1 onto monocytes in patients with peripheral vascular disease. : Arteriosclerosis, thrombosis, and vascular biology.

MLA

Li S R, Yang Q, Koller E, Kurtaran A, Bischof C, Leimer M, Rauscha F, Pidlich J and Virgolini I. Modified LDL decreases the binding of prostaglandin E2, I2, and E1 onto monocytes in patients with peripheral vascular disease. : Arteriosclerosis, thrombosis, and vascular biology. 19971120.